SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision
NCT: NCT07835750 · NOT_YET_RECRUITING
Brief Summary
This randomized controlled trial compares the airway management performance of the SafeLM video laryngeal mask with the LMA Classic in adult patients undergoing elective fibroadenoma excision under general anesthesia. Participants will be randomly assigned to airway management with either the SafeLM or the LMA Classic. The primary outcome is oropharyngeal leak pressure. Secondary outcomes include insertion performance, ventilation parameters, hemodynamic responses, and airway-related adverse events.
Frequently Asked Questions
What is SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision?
SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision is a clinical trial registered under NCT07835750. Current status: NOT_YET_RECRUITING.
What is the status of NCT07835750?
The current status of NCT07835750 (SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision) is: NOT_YET_RECRUITING.
When did SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision start?
SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision started on 2026-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.